Shares in Invitrogen tumbled 14.44 percent for the tracking period ended Tuesday, leading all decliners in the BCW Index this week. The firm missed Wall Street and internal targets for its third quarter at its BioReliance business continues to struggle (see article in this week's issue). Bruker also had a tough week, with its shares dropping 7.43 percent on the heels of its agreement to acquire an X-ray microanalysis business.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.